Financials Orion Oyj

Equities

ORNBV

FI0009014377

Pharmaceuticals

Market Closed - Nasdaq Helsinki 11:29:53 2024-04-26 am EDT 5-day change 1st Jan Change
35.85 EUR +1.30% Intraday chart for Orion Oyj +10.65% -8.71%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,786 5,267 5,119 7,179 5,509 5,044 - -
Enterprise Value (EV) 1 5,647 5,081 5,010 7,060 5,603 5,048 5,038 5,081
P/E ratio 28.9 x 24.1 x 26.5 x 20.6 x 25.5 x 19.8 x 20.2 x 15.6 x
Yield 3.63% 4% 4.11% 3.12% 4.13% 4.6% 4.77% 4.95%
Capitalization / Revenue 5.51 x 4.89 x 4.92 x 5.36 x 4.63 x 3.73 x 3.49 x 3.22 x
EV / Revenue 5.37 x 4.71 x 4.81 x 5.27 x 4.71 x 3.73 x 3.48 x 3.25 x
EV / EBITDA 18.3 x 15.1 x 17.3 x 14.5 x 17.2 x 14.6 x 13.4 x 12.2 x
EV / FCF 24.7 x 20.3 x 38.5 x 21.7 x 105 x 23.9 x 25.9 x 21.4 x
FCF Yield 4.04% 4.93% 2.6% 4.6% 0.95% 4.18% 3.87% 4.68%
Price to Book 7.44 x 7.2 x 6.86 x 7.91 x 6.19 x 5.44 x 5.49 x 5 x
Nbr of stocks (in thousands) 140,492 140,463 140,563 140,202 140,351 140,501 - -
Reference price 2 41.27 37.53 36.52 51.24 39.27 35.85 35.85 35.85
Announcement Date 2/5/20 2/9/21 2/10/22 2/9/23 2/13/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,051 1,078 1,041 1,341 1,190 1,354 1,447 1,565
EBITDA 1 308.9 336.5 289.1 487.1 326.4 346.4 375.9 416.6
EBIT 1 252.8 280.1 243.3 439.6 274.9 291.7 309.6 366
Operating Margin 24.05% 25.98% 23.37% 32.79% 23.11% 21.55% 21.4% 23.39%
Earnings before Tax (EBT) 1 250.8 278.3 242.3 440.3 271.9 319.8 313.5 407.1
Net income 1 200.4 219.9 193.8 349.5 216.8 254.3 249.2 323.7
Net margin 19.07% 20.4% 18.62% 26.07% 18.22% 18.79% 17.23% 20.69%
EPS 2 1.430 1.560 1.380 2.490 1.540 1.811 1.774 2.299
Free Cash Flow 1 228.2 250.6 130.3 324.8 53.4 210.8 194.8 237.9
FCF margin 21.71% 23.24% 12.52% 24.23% 4.49% 15.57% 13.46% 15.2%
FCF Conversion (EBITDA) 73.88% 74.47% 45.07% 66.68% 16.36% 60.85% 51.82% 57.11%
FCF Conversion (Net income) 113.87% 113.96% 67.23% 92.93% 24.63% 82.9% 78.16% 73.49%
Dividend per Share 2 1.500 1.500 1.500 1.600 1.620 1.650 1.710 1.773
Announcement Date 2/5/20 2/9/21 2/10/22 2/9/23 2/13/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 276.5 270.6 283.7 491.8 294.5 277.9 289.6 301.1 321.1 308.5 313.5 333.3 399.9
EBITDA 1 52.6 83 93.6 257.4 53.2 67.7 59.2 93.5 106 68.5 74.4 73.3 133
EBIT 1 39.9 71.5 82 245.4 40.7 55.5 46.5 80 92.9 56 62.99 68.52 100.4
Operating Margin 14.43% 26.42% 28.9% 49.9% 13.82% 19.97% 16.06% 26.57% 28.93% 18.15% 20.09% 20.56% 25.12%
Earnings before Tax (EBT) 1 39.8 72.1 83.1 244.6 40.5 55.1 45.8 78.5 92.4 54.9 57.45 66 120
Net income 1 32.8 57.3 66.1 194.5 31.7 43.8 36.4 61.4 75.1 43.8 45.7 52.6 94.9
Net margin 11.86% 21.18% 23.3% 39.55% 10.76% 15.76% 12.57% 20.39% 23.39% 14.2% 14.58% 15.78% 23.73%
EPS 2 0.2300 0.4100 0.4700 1.380 0.2300 0.3100 0.2600 0.4400 0.5400 0.3100 0.3333 0.2667 0.5400
Dividend per Share 1.500 - - - 1.600 - - - 1.620 - - - -
Announcement Date 2/10/22 4/28/22 7/15/22 10/20/22 2/9/23 4/27/23 7/17/23 10/26/23 2/13/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 93.3 4.12 - 37
Net Cash position 1 139 186 108 119 - - 5.15 -
Leverage (Debt/EBITDA) - - - - 0.2858 x 0.0119 x - 0.0888 x
Free Cash Flow 1 228 251 130 325 53.4 211 195 238
ROE (net income / shareholders' equity) 25.8% 29.1% 26.2% 42.2% 24.1% 28.1% 26.8% 35.5%
ROA (Net income/ Total Assets) 18.4% 29.1% 17.4% 26.7% 14.7% 14.4% 13.9% 15.6%
Assets 1 1,091 755.4 1,115 1,309 1,471 1,761 1,796 2,077
Book Value Per Share 2 5.550 5.210 5.320 6.480 6.340 6.590 6.530 7.170
Cash Flow per Share 2 1.930 2.130 1.540 3.090 0.8500 2.230 2.000 2.800
Capex 1 42.6 48.5 85.4 73.1 117 80.9 79.1 88.5
Capex / Sales 4.05% 4.5% 8.2% 5.45% 9.82% 5.98% 5.46% 5.66%
Announcement Date 2/5/20 2/9/21 2/10/22 2/9/23 2/13/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
35.85 EUR
Average target price
39.2 EUR
Spread / Average Target
+9.34%
Consensus